JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wong, B. R.
Right arrow Articles by Choi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, B. R.
Right arrow Articles by Choi, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 43, 28355-28359, October 23, 1998

The TRAF Family of Signal Transducers Mediates NF-kappa B Activation by the TRANCE Receptor

Brian R. WongDagger , Régis Josien§, Soo Young Lee, Masha VologodskaiaDagger , Ralph M. Steinman§, and Yongwon ChoiDagger parallel

From the parallel  Howard Hughes Medical Institute, Dagger  Laboratory of Immunology, and § Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, New York 10021 and  Department of Pathology, Hallym University, Chunchon, Kangwon-Do 200-702, Korea

Tumor necrosis factor (TNF)-related activation-induced cytokine (TRANCE), a member of the TNF family expressed on activated T-cells, bone marrow stromal cells, and osteoblasts, regulates the function of dendritic cells (DC) and osteoclasts. The TRANCE receptor (TRANCE-R), recently identified as receptor activator of NF-kappa beta (RANK), activates NF-kappa B, a transcription factor critical in the differentiation and activation of those cells. In this report we identify the TNF receptor-associated factor (TRAF) family of signal transducers as important components of TRANCE-R-mediated NF-kappa B activation. Coimmunoprecipitation experiments suggested potential interactions between the cytoplasmic tail of TRANCE-R with TRAF1, TRAF2, TRAF3, TRAF5, and TRAF6. Dominant negative forms of TRAF2, TRAF5, and TRAF6 and an endogenous inhibitor of TRAF2, TRAF-interacting protein (TRIP), substantially inhibited TRANCE-R-mediated NF-kappa B activation, suggesting a role of TRAFs in regulating DC and osteoclast function. Overexpression of combinations of TRAF dominant negative proteins revealed competition between TRAF proteins for the TRANCE-R and the possibility of a TRAF-independent NF-kappa B pathway. Analysis of TRANCE-R deletion mutants suggested that the TRAF2 and TRAF5 interaction sites were restricted to the C-terminal 93 amino acids (C-region). TRAF6 also complexed to the C-region in addition to several regions N-terminal to the TRAF2 and TRAF5 association sites. Furthermore, transfection experiments with TRANCE-R deletion mutants revealed that multiple regions of the TRANCE-R can mediate NF-kappa B activation.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Infect. Immun.Home page
S. N. Somayaji, S. Ritchie, M. Sahraei, I. Marriott, and M. C. Hudson
Staphylococcus aureus Induces Expression of Receptor Activator of NF-{kappa}B Ligand and Prostaglandin E2 in Infected Murine Osteoblasts
Infect. Immun., November 1, 2008; 76(11): 5120 - 5126.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Chen, X. Wang, L. Di, G. Fu, Y. Chen, L. Bai, J. Liu, X. Feng, J. M. McDonald, S. Michalek, et al.
Phospholipase C{gamma}2 Mediates RANKL-stimulated Lymph Node Organogenesis and Osteoclastogenesis
J. Biol. Chem., October 24, 2008; 283(43): 29593 - 29601.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Kuroda, C. Hisatsune, T. Nakamura, K. Matsuo, and K. Mikoshiba
Osteoblasts induce Ca2+ oscillation-independent NFATc1 activation during osteoclastogenesis
PNAS, June 24, 2008; 105(25): 8643 - 8648.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Lorenzo, M. Horowitz, and Y. Choi
Osteoimmunology: Interactions of the Bone and Immune System
Endocr. Rev., June 1, 2008; 29(4): 403 - 440.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-M. Oh, S.-H. Lee, B.-J. Lee, C.-W. Pyo, N.-K. Yoo, S. Y. Lee, J. Kim, and S.-Y. Choi
A Distinct Role of Neutrophil Lactoferrin in RelA/p65 Phosphorylation on Ser536 by Recruiting TNF Receptor-Associated Factors to I{kappa}B Kinase Signaling Complex
J. Immunol., November 1, 2007; 179(9): 5686 - 5692.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Sharma, A. Bronisz, R. Hu, K. Patel, K. C. Mansky, S. Sif, and M. C. Ostrowski
MITF and PU.1 Recruit p38 MAPK and NFATc1 to Target Genes during Osteoclast Differentiation
J. Biol. Chem., May 25, 2007; 282(21): 15921 - 15929.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Xia, W. Ling, H. Zhu, Q. Wang, J. Ma, M. Hou, Z. Tang, L. Li, and Q. Ye
Anthocyanin Prevents CD40-Activated Proinflammatory Signaling in Endothelial Cells by Regulating Cholesterol Distribution
Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 519 - 524.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Sabbagh, C. C. Srokowski, G. Pulle, L. M. Snell, B. J. Sedgmen, Y. Liu, E. N. Tsitsikov, and T. H. Watts
A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival
PNAS, December 5, 2006; 103(49): 18703 - 18708.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Hikita, I. Yana, H. Wakeyama, M. Nakamura, Y. Kadono, Y. Oshima, K. Nakamura, M. Seiki, and S. Tanaka
Negative Regulation of Osteoclastogenesis by Ectodomain Shedding of Receptor Activator of NF-{kappa}B Ligand
J. Biol. Chem., December 1, 2006; 281(48): 36846 - 36855.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Ikeda, R. Nishimura, T. Matsubara, K. Hata, S. V. Reddy, and T. Yoneda
Activation of NFAT Signal In Vivo Leads to Osteopenia Associated with Increased Osteoclastogenesis and Bone-Resorbing Activity
J. Immunol., August 15, 2006; 177(4): 2384 - 2390.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. E. Frigo, A. Basu, E. N. Nierth-Simpson, C. B. Weldon, C. M. Dugan, S. Elliott, B. M. Collins-Burow, V. A. Salvo, Y. Zhu, L. I. Melnik, et al.
p38 Mitogen-Activated Protein Kinase Stimulates Estrogen-Mediated Transcription and Proliferation through the Phosphorylation and Potentiation of the p160 Coactivator Glucocorticoid Receptor-Interacting Protein 1
Mol. Endocrinol., May 1, 2006; 20(5): 971 - 983.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
H. Yoshida, K. Okamoto, T. Iwamoto, E. Sakai, K. Kanaoka, J.-P. Hu, M. Shibata, H. Hotokezaka, K. Nishishita, A. Mizuno, et al.
Pepstatin A, an Aspartic Proteinase Inhibitor, Suppresses RANKL-Induced Osteoclast Differentiation.
J. Biochem., March 1, 2006; 139(3): 583 - 590.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Xu, S. Wang, W. Liu, J. Liu, and X. Feng
A Novel Receptor Activator of NF-{kappa}B (RANK) Cytoplasmic Motif Plays an Essential Role in Osteoclastogenesis by Committing Macrophages to the Osteoclast Lineage
J. Biol. Chem., February 24, 2006; 281(8): 4678 - 4690.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Hikita, Y. Kadono, H. Chikuda, A. Fukuda, H. Wakeyama, H. Yasuda, K. Nakamura, H. Oda, T. Miyazaki, and S. Tanaka
Identification of an Alternatively Spliced Variant of Ca2+-promoted Ras Inactivator as a Possible Regulator of RANKL Shedding
J. Biol. Chem., December 16, 2005; 280(50): 41700 - 41706.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Rogers and R. Eastell
Circulating Osteoprotegerin and Receptor Activator for Nuclear Factor {kappa}B Ligand: Clinical Utility in Metabolic Bone Disease Assessment
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6323 - 6331.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Y.-I. Lee, D.-W. Kim, J. A. Karmin, D. Hong, S.-S. Chang, M. Fujisawa, H. Takayanagi, L. U. Bigliani, T. A. Blaine, and H.-J. Lee
{micro}-Calpain Regulates Receptor Activator of NF-{kappa}B Ligand (RANKL)-supported Osteoclastogenesis via NF-{kappa}B Activation in RAW 264.7 Cells
J. Biol. Chem., August 19, 2005; 280(33): 29929 - 29936.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-K. Min, Y.-M. Kim, S. W. Kim, M.-C. Kwon, Y.-Y. Kong, I. K. Hwang, M. H. Won, J. Rho, and Y.-G. Kwon
TNF-Related Activation-Induced Cytokine Enhances Leukocyte Adhesiveness: Induction of ICAM-1 and VCAM-1 via TNF Receptor-Associated Factor and Protein Kinase C-Dependent NF-{kappa}B Activation in Endothelial Cells
J. Immunol., July 1, 2005; 175(1): 531 - 540.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Kobayashi, T. Mizoguchi, I. Take, S. Kurihara, N. Udagawa, and N. Takahashi
Prostaglandin E2 Enhances Osteoclastic Differentiation of Precursor Cells through Protein Kinase A-dependent Phosphorylation of TAK1
J. Biol. Chem., March 25, 2005; 280(12): 11395 - 11403.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Liu, D. Xu, H. Yang, H. Xu, Z. Shi, X. Cao, S. Takeshita, J. Liu, M. Teale, and X. Feng
Functional Identification of Three Receptor Activator of NF-{kappa}B Cytoplasmic Motifs Mediating Osteoclast Differentiation and Function
J. Biol. Chem., December 24, 2004; 279(52): 54759 - 54769.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Takada and B. B. Aggarwal
Evidence that genetic deletion of the TNF receptor p60 or p80 in macrophages modulates RANKL-induced signaling
Blood, December 15, 2004; 104(13): 4113 - 4121.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Matsumoto, M. Kogawa, S. Wada, H. Takayanagi, M. Tsujimoto, S. Katayama, K. Hisatake, and Y. Nogi
Essential Role of p38 Mitogen-activated Protein Kinase in Cathepsin K Gene Expression during Osteoclastogenesis through Association of NFATc1 and PU.1
J. Biol. Chem., October 29, 2004; 279(44): 45969 - 45979.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. M. Doherty, L. A. Fitzpatrick, D. Inoue, J.-H. Qiao, M. C. Fishbein, R. C. Detrano, P. K. Shah, and T. B. Rajavashisth
Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification
Endocr. Rev., August 1, 2004; 25(4): 629 - 672.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. D. Jang, K. Yoon, Y. J. Shin, J. Kim, and S. Y. Lee
PIAS3 Suppresses NF-{kappa}B-mediated Transcription by Interacting with the p65/RelA Subunit
J. Biol. Chem., June 4, 2004; 279(23): 24873 - 24880.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. C. Bharti, Y. Takada, and B. B. Aggarwal
Curcumin (Diferuloylmethane) Inhibits Receptor Activator of NF-{kappa}B Ligand-Induced NF-{kappa}B Activation in Osteoclast Precursors and Suppresses Osteoclastogenesis
J. Immunol., May 15, 2004; 172(10): 5940 - 5947.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. J. Philpott, M. Nociari, K. B. Elkon, and E. Falck-Pedersen
Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-{alpha} induction pathway
PNAS, April 20, 2004; 101(16): 6200 - 6205.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Saito, N. Ohara, H. Hotokezaka, S. Fukumoto, K. Yuasa, M. Naito, T. Fujiwara, and K. Nakayama
Infection-induced Up-regulation of the Costimulatory Molecule 4-1BB in Osteoblastic Cells and Its Inhibitory Effect on M-CSF/RANKL-induced in Vitro Osteoclastogenesis
J. Biol. Chem., April 2, 2004; 279(14): 13555 - 13563.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Hirotani, N. A. Tuohy, J.-T. Woo, P. H. Stern, and N. A. Clipstone
The Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway Regulates Osteoclastogenesis in RAW264.7 Cells
J. Biol. Chem., April 2, 2004; 279(14): 13984 - 13992.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. C. Bharti, Y. Takada, S. Shishodia, and B. B. Aggarwal
Evidence That Receptor Activator of Nuclear Factor (NF)-{kappa}B Ligand Can Suppress Cell Proliferation and Induce Apoptosis through Activation of a NF-{kappa}B-independent and TRAF6-dependent Mechanism
J. Biol. Chem., February 13, 2004; 279(7): 6065 - 6076.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Chiffoleau, T. Kobayashi, M. C. Walsh, C. G. King, P. T. Walsh, W. W. Hancock, Y. Choi, and L. A. Turka
TNF Receptor-Associated Factor 6 Deficiency during Hemopoiesis Induces Th2-Polarized Inflammatory Disease
J. Immunol., December 1, 2003; 171(11): 5751 - 5759.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-K. Min, Y.-M. Kim, Y.-M. Kim, E.-C. Kim, Y. S. Gho, I.-J. Kang, S.-Y. Lee, Y.-Y. Kong, and Y.-G. Kwon
Vascular Endothelial Growth Factor Up-regulates Expression of Receptor Activator of NF-{kappa}B (RANK) in Endothelial Cells: CONCOMITANT INCREASE OF ANGIOGENIC RESPONSES TO RANK LIGAND
J. Biol. Chem., October 10, 2003; 278(41): 39548 - 39557.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Zhang, E. Jimi, and A. L. M. Bothwell
Receptor Activator of NF-{kappa}B Ligand Stimulates Recruitment of SHP-1 to the Complex Containing TNFR-Associated Factor 6 That Regulates Osteoclastogenesis
J. Immunol., October 1, 2003; 171(7): 3620 - 3626.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Younes and M. E. Kadin
Emerging Applications of the Tumor Necrosis Factor Family of Ligands and Receptors in Cancer Therapy
J. Clin. Oncol., September 15, 2003; 21(18): 3526 - 3534.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. So, J. Rho, D. Jeong, R. Park, D. E. Fisher, M. C. Ostrowski, Y. Choi, and N. Kim
Microphthalmia Transcription Factor and PU.1 Synergistically Induce the Leukocyte Receptor Osteoclast-associated Receptor Gene Expression
J. Biol. Chem., June 20, 2003; 278(26): 24209 - 24216.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Ha, H. B. Kwak, S. K. Lee, D. S. Na, C. E. Rudd, Z. H. Lee, and H.-H. Kim
Membrane Rafts Play a Crucial Role in Receptor Activator of Nuclear Factor kappa B Signaling and Osteoclast Function
J. Biol. Chem., May 9, 2003; 278(20): 18573 - 18580.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Itoh, N. Udagawa, K. Kobayashi, K. Suda, X. Li, M. Takami, N. Okahashi, T. Nishihara, and N. Takahashi
Lipopolysaccharide Promotes the Survival of Osteoclasts Via Toll-Like Receptor 4, but Cytokine Production of Osteoclasts in Response to Lipopolysaccharide Is Different from That of Macrophages
J. Immunol., April 1, 2003; 170(7): 3688 - 3695.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. V. Komarova, M. F. Pilkington, A. F. Weidema, S. J. Dixon, and S. M. Sims
RANK Ligand-induced Elevation of Cytosolic Ca2+ Accelerates Nuclear Translocation of Nuclear Factor kappa B in Osteoclasts
J. Biol. Chem., February 28, 2003; 278(10): 8286 - 8293.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Hotokezaka, E. Sakai, K. Kanaoka, K. Saito, K.-i. Matsuo, H. Kitaura, N. Yoshida, and K. Nakayama
U0126 and PD98059, Specific Inhibitors of MEK, Accelerate Differentiation of RAW264.7 Cells into Osteoclast-like Cells
J. Biol. Chem., November 27, 2002; 277(49): 47366 - 47372.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Armstrong, M. E. Tometsko, M. Glaccum, C. L. Sutherland, D. Cosman, and W. C. Dougall
A RANK/TRAF6-dependent Signal Transduction Pathway Is Essential for Osteoclast Cytoskeletal Organization and Resorptive Function
J. Biol. Chem., November 8, 2002; 277(46): 44347 - 44356.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
D H. Jones, Y-Y Kong, and J M Penninger
Role of RANKL and RANK in bone loss and arthritis
Ann Rheum Dis, November 1, 2002; 61(90002): ii32 - 39.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Ishida, K. Hayashi, M. Hoshijima, T. Ogawa, S. Koga, Y. Miyatake, M. Kumegawa, T. Kimura, and T. Takeya
Large Scale Gene Expression Analysis of Osteoclastogenesis in Vitro and Elucidation of NFAT2 as a Key Regulator
J. Biol. Chem., October 18, 2002; 277(43): 41147 - 41156.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. R. Arron, Y. Pewzner-Jung, M. C. Walsh, T. Kobayashi, and Y. Choi
Regulation of the Subcellular Localization of Tumor Necrosis Factor Receptor-associated Factor (TRAF)2 by TRAF1 Reveals Mechanisms of TRAF2 Signaling
J. Exp. Med., October 7, 2002; 196(7): 923 - 934.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Cannons, E. M. Bertram, and T. H. Watts
Cutting Edge: Profound Defect in T Cell Responses in TNF Receptor-Associated Factor 2 Dominant Negative Mice
J. Immunol., September 15, 2002; 169(6): 2828 - 2831.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Li, N. Udagawa, K. Itoh, K. Suda, Y. Murase, T. Nishihara, T. Suda, and N. Takahashi
p38 MAPK-Mediated Signals Are Required for Inducing Osteoclast Differentiation But Not for Osteoclast Function
Endocrinology, August 1, 2002; 143(8): 3105 - 3113.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hayashi, T. Kaneda, Y. Toyama, M. Kumegawa, and Y. Hakeda
Regulation of Receptor Activator of NF-kappa B Ligand-induced Osteoclastogenesis by Endogenous Interferon-beta (INF-beta ) and Suppressors of Cytokine Signaling (SOCS). THE POSSIBLE COUNTERACTING ROLE OF SOCSs IN IFN-beta -INHIBITED OSTEOCLAST FORMATION
J. Biol. Chem., July 26, 2002; 277(31): 27880 - 27886.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Cappellen, N.-H. Luong-Nguyen, S. Bongiovanni, O. Grenet, C. Wanke, and M. Susa
Transcriptional Program of Mouse Osteoclast Differentiation Governed by the Macrophage Colony-stimulating Factor and the Ligand for the Receptor Activator of NFkappa B
J. Biol. Chem., June 7, 2002; 277(24): 21971 - 21982.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. C. Mansky, U. Sankar, J. Han, and M. C. Ostrowski
Microphthalmia Transcription Factor Is a Target of the p38 MAPK Pathway in Response to Receptor Activator of NF-kappa B Ligand Signaling
J. Biol. Chem., March 22, 2002; 277(13): 11077 - 11083.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-M. Kim, Y.-M. Kim, Y. M. Lee, H.-S. Kim, J. D. Kim, Y. Choi, K.-W. Kim, S.-Y. Lee, and Y.-G. Kwon
TNF-related Activation-induced Cytokine (TRANCE) Induces Angiogenesis through the Activation of Src and Phospholipase C (PLC) in Human Endothelial Cells
J. Biol. Chem., February 22, 2002; 277(9): 6799 - 6805.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Mizukami, G. Takaesu, H. Akatsuka, H. Sakurai, J. Ninomiya-Tsuji, K. Matsumoto, and N. Sakurai
Receptor Activator of NF-{kappa}B Ligand (RANKL) Activates TAK1 Mitogen-Activated Protein Kinase Kinase Kinase through a Signaling Complex Containing RANK, TAB2, and TRAF6
Mol. Cell. Biol., February 15, 2002; 22(4): 992 - 1000.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. Y. Chung, Y. C. Park, H. Ye, and H. Wu
All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction
J. Cell Sci., February 15, 2002; 115(4): 679 - 688.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Fiumara, V. Snell, Y. Li, A. Mukhopadhyay, M. Younes, A. M. Gillenwater, F. Cabanillas, B. B. Aggarwal, and A. Younes
Functional expression of receptor activator of nuclear factor kappa B in Hodgkin disease cell lines
Blood, November 1, 2001; 98(9): 2784 - 2790.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. H. Lee, K. Kwack, K. K. Kim, S. H. Lee, and H.-H. Kim
Activation of c-Jun N-Terminal Kinase and Activator Protein 1 by Receptor Activator of Nuclear Factor kappa B
Mol. Pharmacol., April 13, 2001; 58(6): 1536 - 1545.
[Abstract] [Full Text]


Home page
Cell Growth Differ.Home page
G. R. Beck Jr., B. Zerler, and E. Moran
Gene Array Analysis of Osteoblast Differentiation
Cell Growth Differ., February 1, 2001; 12(2): 61 - 83.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
L. Xing, A. M. Venegas, A. Chen, L. Garrett-Beal, B. F. Boyce, H. E. Varmus, and P. L. Schwartzberg
Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival
Genes & Dev., January 15, 2001; 15(2): 241 - 253.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
T. Kaneda, T. Nojima, M. Nakagawa, A. Ogasawara, H. Kaneko, T. Sato, H. Mano, M. Kumegawa, and Y. Hakeda
Endogenous Production of TGF-{beta} Is Essential for Osteoclastogenesis Induced by a Combination of Receptor Activator of NF-{kappa}B Ligand and Macrophage-Colony- Stimulating Factor
J. Immunol., October 15, 2000; 165(8): 4254 - 4263.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. S. Kornbluth
The emerging role of CD40 ligand in HIV infection
J. Leukoc. Biol., September 1, 2000; 68(3): 373 - 382.
[Abstract] [Full Text] [PDF]